These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8951981)

  • 21. Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.
    Redrobe JP; Bourin M
    Eur J Pharmacol; 1997 May; 325(2-3):129-35. PubMed ID: 9163559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms.
    Kennaway DJ; Moyer RW
    Brain Res; 1998 Sep; 806(2):257-70. PubMed ID: 9739147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI.
    Lawton CL; Blundell JE
    Pharmacol Biochem Behav; 1993 Oct; 46(2):349-60. PubMed ID: 8265689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of serotonin and the 5-HT2/1C receptor agonist DOI on neurons of the cerebellar dentate/interpositus nuclei: possible involvement of a GABAergic interneuron.
    Cumming-Hood PA; Strahlendorf HK; Strahlendorf JC
    Eur J Pharmacol; 1993 Jun; 236(3):457-65. PubMed ID: 8359203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
    Done CJ; Sharp T
    Br J Pharmacol; 1992 Sep; 107(1):240-5. PubMed ID: 1422575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW; Ogilvie J; Houghton AK
    Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta.
    Siddiqui A; Abu-Amara M; Aldairy C; Hagan JJ; Wilson C
    Eur J Pharmacol; 2004 Apr; 491(1):77-84. PubMed ID: 15102536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of (+/-)-DOI on medial prefrontal cortical cells: a microiontophoretic study.
    Ashby CR; Edwards E; Harkins K; Wang RY
    Brain Res; 1989 Oct; 498(2):393-6. PubMed ID: 2790491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of acute pharmacological manipulation of central serotonin neurotransmission on osmoregulated secretion of arginine vasopressin in the rat.
    Faull CM; Charlton JA; Butler TJ; Baylis PH
    J Endocrinol; 1993 Oct; 139(1):77-87. PubMed ID: 8254296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
    Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P
    Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
    Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the 5-HT2C/2B receptor agonist 1-(3-chlorophenyl) piperazine on plasma glucose levels of rats.
    Sugimoto Y; Yamada J; Yoshikawa T; Horisaka K
    Eur J Pharmacol; 1996 Jun; 307(1):75-80. PubMed ID: 8831107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonergic modulation of nicotine-induced kinetic tremor in mice.
    Kunisawa N; Iha HA; Nomura Y; Onishi M; Matsubara N; Shimizu S; Ohno Y
    J Pharmacol Sci; 2017 Jun; 134(2):131-138. PubMed ID: 28647281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential involvement of 5-HT(2A) receptors in the discriminative-stimulus effects of cocaine and methamphetamine.
    Munzar P; Justinova Z; Kutkat SW; Goldberg SR
    Eur J Pharmacol; 2002 Feb; 436(1-2):75-82. PubMed ID: 11834249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action of serotonin in the medial prefrontal cortex: mediation by serotonin3-like receptors.
    Ashby CR; Edwards E; Wang RY
    Synapse; 1992 Jan; 10(1):7-15. PubMed ID: 1536032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic cocaine exposure potentiates prolactin and head shake responses to 5-HT2 receptor stimulation in rats.
    Baumann MH; Rothman RB
    Neuropharmacology; 1996 Mar; 35(3):295-301. PubMed ID: 8783204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
    Chaouloff F; Laude D; Baudrie V
    Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Peripheral and central participation in hemodynamic effects of serotonin2 receptor stimulation].
    Chaouche-Teyara K; Dabiré H; Fournier B; Safar M
    Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1257-61. PubMed ID: 8129539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The serotonin2 antagonist ritanserin blocks quasi-morphine withdrawal at a time when mianserin is no longer effective.
    Neal BS; Sparber SB
    Psychopharmacology (Berl); 1990; 100(2):258-66. PubMed ID: 1689501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of 5-HT2 receptor-mediated head-twitch response by cocaine via indirect stimulation of adrenergic alpha 2 and serotonergic 5-HT1A receptors.
    Darmani NA; Martin BR; Pandey U; Glennon RA
    Pharmacol Biochem Behav; 1991 Feb; 38(2):353-7. PubMed ID: 1676173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.